Loading insider details...
Beta
Latest Form 4 (Aug 31, 2026): Exercise/Conversion of 41,927 COGT shares, $236.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 31, 2026 | Cogent Biosciences, Inc. (COGT) | Exercise/Conversion | 41,927 | $236.5K |
| Aug 5, 2026 | PALATIN TECHNOLOGIES INC (PTN) | Voting Trust | 2,400 | n/a |
| Jul 2, 2026 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/Award | 32,341 | n/a |
| Jun 17, 2026 | Edgewise Therapeutics, Inc. (EWTX) | Grant/Award | 16,377 | n/a |
| Jun 11, 2026 | Cogent Biosciences, Inc. (COGT) | Grant/Award | 17,901 | n/a |
| Dec 11, 2025 | PALATIN TECHNOLOGIES INC (PTN) | Grant/Award | 2,400 | n/a |
| Jul 2, 2025 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/Award | 21,000 | n/a |
| Jun 18, 2025 | Edgewise Therapeutics, Inc. (EWTX) | Grant/Award | 30,000 | n/a |
| Jun 5, 2025 | Cogent Biosciences, Inc. (COGT) | Grant/Award | 44,700 | n/a |
| Jul 16, 2024 | PALATIN TECHNOLOGIES INC (PTN) | Grant/Award | 12,000 | n/a |